Yes ND the reality is if BD1 can deliver a worlds first blood test for Ovarian, Breast and Lung cancer then this stock will provide a lot for patient shareholders going forward.
I have a question for the forum. Does anyone know if the tests will require FDA approval in the US?
The reason I ask is 2021 is only 18 short months away.
In yhat time we will need to have successful Luminex adaptation, clinical trials, production/royalty contract/distribution contract and maybe FDA approval???....its a pretty full dance card.
Chart, page-3277
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.005(0.85%) |
Mkt cap ! $65.61M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 59.5¢ | $3.887K | 6.533K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3467 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |